These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 21790289)
21. A possible contribution of altered cathepsin B expression to the development of skin sclerosis and vasculopathy in systemic sclerosis. Noda S; Asano Y; Akamata K; Aozasa N; Taniguchi T; Takahashi T; Ichimura Y; Toyama T; Sumida H; Yanaba K; Tada Y; Sugaya M; Kadono T; Sato S PLoS One; 2012; 7(2):e32272. PubMed ID: 22384200 [TBL] [Abstract][Full Text] [Related]
22. Suppressive Regulation by MFG-E8 of Latent Transforming Growth Factor β-Induced Fibrosis via Binding to αv Integrin: Significance in the Pathogenesis of Fibrosis in Systemic Sclerosis. Fujiwara C; Uehara A; Sekiguchi A; Uchiyama A; Yamazaki S; Ogino S; Yokoyama Y; Torii R; Hosoi M; Suto C; Tsunekawa K; Murakami M; Ishikawa O; Motegi SI Arthritis Rheumatol; 2019 Feb; 71(2):302-314. PubMed ID: 30175895 [TBL] [Abstract][Full Text] [Related]
23. Fibroblast abnormalities in the pathogenesis of systemic sclerosis. Usategui A; del Rey MJ; Pablos JL Expert Rev Clin Immunol; 2011 Jul; 7(4):491-8. PubMed ID: 21790292 [TBL] [Abstract][Full Text] [Related]
24. Dysregulation of transforming growth factor beta signaling in scleroderma: overexpression of endoglin in cutaneous scleroderma fibroblasts. Leask A; Abraham DJ; Finlay DR; Holmes A; Pennington D; Shi-Wen X; Chen Y; Venstrom K; Dou X; Ponticos M; Black C; Bernabeu C; Jackman JK; Findell PR; Connolly MK Arthritis Rheum; 2002 Jul; 46(7):1857-65. PubMed ID: 12124870 [TBL] [Abstract][Full Text] [Related]
25. Expression of allograft inflammatory factor 1 in tissues from patients with systemic sclerosis and in vitro differential expression of its isoforms in response to transforming growth factor beta. Del Galdo F; Maul GG; Jiménez SA; Artlett CM Arthritis Rheum; 2006 Aug; 54(8):2616-25. PubMed ID: 16868985 [TBL] [Abstract][Full Text] [Related]
26. Genome-wide whole blood transcriptome profiling in a large European cohort of systemic sclerosis patients. Beretta L; Barturen G; Vigone B; Bellocchi C; Hunzelmann N; De Langhe E; Cervera R; Gerosa M; Kovács L; Ortega Castro R; Almeida I; Cornec D; Chizzolini C; Pers JO; Makowska Z; Lesche R; Kerick M; Alarcón-Riquelme ME; Martin J; ; Ann Rheum Dis; 2020 Sep; 79(9):1218-1226. PubMed ID: 32561607 [TBL] [Abstract][Full Text] [Related]
27. New insights into the pathogenesis of systemic sclerosis. Tamby MC; Chanseaud Y; Guillevin L; Mouthon L Autoimmun Rev; 2003 May; 2(3):152-7. PubMed ID: 12848956 [TBL] [Abstract][Full Text] [Related]
28. Genetic Interactions Affect Lung Function in Patients with Systemic Sclerosis. Tyler A; Mahoney JM; Carter GW G3 (Bethesda); 2020 Jan; 10(1):151-163. PubMed ID: 31694854 [TBL] [Abstract][Full Text] [Related]
29. Limited cutaneous systemic sclerosis skin demonstrates distinct molecular subsets separated by a cardiovascular development gene expression signature. Derrett-Smith EC; Martyanov V; Chighizola CB; Moinzadeh P; Campochiaro C; Khan K; Wood TA; Meroni PL; Abraham DJ; Ong VH; Lafyatis R; Whitfield ML; Denton CP Arthritis Res Ther; 2017 Jul; 19(1):156. PubMed ID: 28676069 [TBL] [Abstract][Full Text] [Related]
30. Analysis of gene expression profiles and protein-protein interaction networks in multiple tissues of systemic sclerosis. Karimizadeh E; Sharifi-Zarchi A; Nikaein H; Salehi S; Salamatian B; Elmi N; Gharibdoost F; Mahmoudi M BMC Med Genomics; 2019 Dec; 12(1):199. PubMed ID: 31881890 [TBL] [Abstract][Full Text] [Related]
31. Role of Stromelysin 2 (Matrix Metalloproteinase 10) as a Novel Mediator of Vascular Remodeling Underlying Pulmonary Hypertension Associated With Systemic Sclerosis. Avouac J; Guignabert C; Hoffmann-Vold AM; Ruiz B; Dorfmuller P; Pezet S; Amar O; Tu L; Van Wassenhove J; Sadoine J; Launay D; Elhai M; Cauvet A; Subramaniam A; Resnick R; Hachulla E; Molberg Ø; Kahan A; Humbert M; Allanore Y Arthritis Rheumatol; 2017 Nov; 69(11):2209-2221. PubMed ID: 28805015 [TBL] [Abstract][Full Text] [Related]
37. Scleroderma gene expression and pathway signatures. Sargent JL; Milano A; Connolly MK; Whitfield ML Curr Rheumatol Rep; 2008 Jul; 10(3):205-11. PubMed ID: 18638428 [TBL] [Abstract][Full Text] [Related]
38. The role of endothelin-1 signaling in the fibrosis observed in systemic sclerosis. Leask A Pharmacol Res; 2011 Jun; 63(6):502-3. PubMed ID: 21315153 [TBL] [Abstract][Full Text] [Related]
39. The transcription factor GLI2 as a downstream mediator of transforming growth factor-β-induced fibroblast activation in SSc. Liang R; Šumová B; Cordazzo C; Mallano T; Zhang Y; Wohlfahrt T; Dees C; Ramming A; Krasowska D; Michalska-Jakubus M; Distler O; Schett G; Šenolt L; Distler JH Ann Rheum Dis; 2017 Apr; 76(4):756-764. PubMed ID: 27793816 [TBL] [Abstract][Full Text] [Related]
40. Elevated Fibronectin Levels in Profibrotic CD14 Rudnik M; Hukara A; Kocherova I; Jordan S; Schniering J; Milleret V; Ehrbar M; Klingel K; Feghali-Bostwick C; Distler O; Błyszczuk P; Kania G Front Immunol; 2021; 12():642891. PubMed ID: 34504485 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]